Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | PI4KA | P42356 | 1/20 | 0.43 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.43 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.43 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | DHFR | P00374 | 3/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | AKT1 | P31749 | 1/20 | 0.39 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30507756 | 1.00 | MEN1 (0.46) | MEN1KMT2AHSP90AA1MAPTAVPR1A | |
| SCHEMBL28576110 | 0.98 | GAA (0.44) | MEN1KMT2AHSP90AA1MAPTAVPR1A | |
| SCHEMBL21195750 | 0.95 | MEN1 (0.48) | MEN1KMT2AHSP90AA1MAPTAVPR1A | |
| SCHEMBL31109976 | 0.95 | MEN1 (0.48) | MEN1KMT2AHSP90AA1MAPTAVPR1A | |
| SCHEMBL2631757 | 0.95 | MEN1 (0.48) | MEN1KMT2AHSP90AA1MAPTAVPR1A | |
| SCHEMBL21195691 | 0.93 | MEN1 (0.53) | MEN1KMT2AHSP90AA1MAPTAVPR1A | |
| SCHEMBL28560074 | 0.93 | GAA (0.42) | MEN1KMT2AHSP90AA1MAPTAVPR1A | |
| SCHEMBL1696798 | 0.92 | ALDH1A1 (0.52) | MEN1KMT2AMAPTAVPR1AGAA | |
| SCHEMBL23265180 | 0.91 | GAA (0.40) | MEN1KMT2AHSP90AA1MAPTAVPR1A | |
| SCHEMBL19534171 | 0.91 | GAA (0.40) | MEN1KMT2AHSP90AA1MAPTAVPR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4250899-A2 | ORGANIC ELECTROLUMINESCENT DEVICE | Samsung Display Co., Ltd. (KR) | 2023-09-27 | — | — | EP | disclosed |
| EP-3639308-B1 | ORGANIC ELECTROLUMINESCENT DEVICE | SAMSUNG DISPLAY CO LTD (KR) | 2023-07-26 | — | — | EP | disclosed |
| EP-3809479-B1 | ORGANIC ELECTROLUMINESCENT DEVICE EMITTING BLUE LIGHT | SAMSUNG DISPLAY CO LTD (KR) | 2023-07-12 | — | — | EP | disclosed |
| US-11165035-B2 | Organic electroluminescent device emitting blue light | CYNORA GMBH (DE) | 2021-11-02 | — | — | US | disclosed |
| EP-3483156-B1 | ORGANIC MOLECUES FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2020-09-16 | — | — | EP | disclosed |
| EP-3613744-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2020-02-26 | — | — | EP | disclosed |
| US-20190177303-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2019-06-13 | — | — | US | disclosed |
| EP-3483156-A1 | ORGANIC MOLECUES FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2019-05-15 | — | — | EP | disclosed |
| US-9917270-B1 | Organic electroluminescent device having an exciton quenching layer | CYNORA GMBH (DE) | 2018-03-13 | — | — | US | disclosed |
| US-9917270-B1 | Organic electroluminescent device having an exciton quenching layer | CYNORA GMBH (DE) | 2018-03-13 | — | — | US | disclosed |
| US-8048542-B2 | Bis-phenanthroimidazolyl compound and electroluminescent device using the same | NATIONAL TSING HUA UNIVERSITY (TW) | 2011-11-01 | — | — | US | disclosed |
| US-20100253208-A1 | BIS-PHENANTHROIMIDAZOLYL COMPOUND AND ELECTROLUMINESCENT DEVICE USING THE SAME | E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) | 2010-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100253208-A1 | BIS-PHENANTHROIMIDAZOLYL COMPOUND AND ELECTROLUMINESCENT DEVICE USING THE SAME | SLC43A3, SLC29A1, SLC29A2 | MEN1 2505/4885KMT2A 2701/4885HSP90AA1 1194/4885 |
| US-20190177303-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | OR10J3, ORC3, OR51E2 | MEN1 3148/4885KMT2A 3925/4885HSP90AA1 4861/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.